Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Study Details page appears unchanged between screenshots; there are no alterations to the trial title, interventions, outcomes, or eligibility criteria.
    Difference
    0.1%
    Check dated 2025-11-02T00:54:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: region name updated from Rhone-Alpes to Auvergne-Rhône-Alpes with a new Pierre-Bénite entry; page version bumped to v3.2.0; added government operating-status notice.
    Difference
    3%
    Check dated 2025-10-04T12:14:07.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.
    Difference
    0.2%
    Check dated 2025-09-27T07:52:26.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Location labels updated to use 'Respublika' instead of 'Republic' (e.g., 'Tatarstan Republic Locations' -> 'Tatarstan, Respublika Locations'; 'Kazan, Tatarstan Republic, Russia, 420029' -> 'Kazan, Tatarstan, Respublika, Russia, 420029'); version bumped to v3.0.2; 'Back to Top' removed.
    Difference
    0.2%
    Check dated 2025-09-13T01:45:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.1%
    Check dated 2025-09-05T19:55:49.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility locations across various countries and the inclusion of drug information for multiple medications, while some previous location entries and drug-related topics have been removed.
    Difference
    21%
    Check dated 2025-08-29T16:37:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.